VOYA Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
166,184
+100,461
| +153% | +$1.75M | ﹤0.01% | 1156 |
|
|
2025
Q1 | $827K | Sell |
65,723
-1,554
| -2% | -$19.5K | ﹤0.01% | 1650 |
|
|
2024
Q4 | $710K | Buy |
67,277
+19,381
| +40% | +$204K | ﹤0.01% | 1782 |
|
|
2024
Q3 | $694K | Buy |
47,896
+30,589
| +177% | +$444K | ﹤0.01% | 1824 |
|
|
2024
Q2 | $147K | Buy |
+17,307
| New | +$147K | ﹤0.01% | 2566 |
|
|
2021
Q2 | – | Sell |
-5,350
| Closed | -$233K | – | 2892 |
|
|
2021
Q1 | $233K | Buy |
+5,350
| New | +$233K | ﹤0.01% | 2450 |
|